Gerald V. Raymond

Professor

1993 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Gerald V. Raymond is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Adrenoleukodystrophy Medicine & Life Sciences
Peroxisomal Disorders Medicine & Life Sciences
Zellweger Syndrome Medicine & Life Sciences
Mutation Medicine & Life Sciences
Peroxisomes Medicine & Life Sciences
Fatty Acids Medicine & Life Sciences
Nervous System Medicine & Life Sciences
Phenotype Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1993 2019

A report on state-wide implementation of newborn screening for X-linked Adrenoleukodystrophy

Wiens, K., Berry, S. A., Choi, H., Gaviglio, A., Gupta, A., Hietala, A., Kenney-Jung, D., Lund, T., Miller, W., Pierpont, E. I., Raymond, G., Winslow, H., Zierhut, H. A. & Orchard, P. J., Jul 2019, In : American Journal of Medical Genetics, Part A. 179, 7, p. 1205-1213 9 p.

Research output: Contribution to journalArticle

Open Access
Adrenoleukodystrophy
Newborn Infant
Adrenal Insufficiency
Lysophosphatidylcholines
Pedigree

Association between APOE4 and biomarkers in cerebral adrenoleukodystrophy

Orchard, P. J., Markowski, T. W., Higgins, L. A., Raymond, G. V., Nascene, D. R., Miller, W. P., Pierpont, E. I. & Lund, T. C., Dec 1 2019, In : Scientific reports. 9, 1, 7858.

Research output: Contribution to journalArticle

Open Access
Adrenoleukodystrophy
Biomarkers
Nervous System
Nervous System Trauma
Gadolinium

Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a Phase II Pilot Study

Casasnovas, C., Ruiz, M., Schlüter, A., Naudí, A., Fourcade, S., Veciana, M., Castañer, S., Albertí, A., Bargalló, N., Johnson, M., Raymond, G. V., Fatemi, A., Moser, A. B., Villarroya, F., Portero-Otín, M., Artuch, R., Pamplona, R. & Pujol, A., Jan 1 2019, In : Neurotherapeutics.

Research output: Contribution to journalArticle

Open Access
Adrenoleukodystrophy
Antioxidants
Biomarkers
Safety
Oxidation-Reduction

Cerebrotendinous xanthomatosis: The rare "treatable" disease you never consider

Raymond, G. V. & Schiffmann, R., Jan 8 2019, In : Neurology. 92, 2, p. 61-62 2 p.

Research output: Contribution to journalEditorial

Cerebrotendinous Xanthomatosis
Rare Diseases

Survival and Functional Outcomes in Boys with Cerebral Adrenoleukodystrophy with and without Hematopoietic Stem Cell Transplantation

Raymond, G. V., Aubourg, P., Paker, A., Escolar, M., Fischer, A., Blanche, S., Baruchel, A., Dalle, J. H., Michel, G., Prasad, V., Miller, W., Paadre, S., Balser, J., Kurtzberg, J., Nascene, D. R., Orchard, P. J. & Lund, T., Mar 2019, In : Biology of Blood and Marrow Transplantation. 25, 3, p. 538-548 11 p.

Research output: Contribution to journalArticle

Open Access
Adrenoleukodystrophy
Hematopoietic Stem Cell Transplantation
Survival
Graft vs Host Disease
Confidence Intervals